As of late, it has definitely been a great time to be an investor in EyePoint Pharmaceuticals, Inc. EYPT. The stock has moved higher by 40% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.
Will EyePoint Pharmaceuticals (EYPT) Continue to Surge Higher?
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться